RiverVest Venture Fund III, L.P. 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-21 6:38 pm Sale | 2025-01-16 | 13D | Reneo Pharmaceuticals, Inc. RPHM | RiverVest Venture Fund III, L.P. | 196,198 1.550% | -57,224 (-22.58%) | Filing |
| 2023-05-30 4:52 pm Purchase | 2023-05-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM | RiverVest Venture Fund III, L.P. | 253,422 7.530% | 12,500 (+5.19%) | Filing |
| 2021-04-19 2:04 pm Purchase | 2021-04-08 | 13D | Reneo Pharmaceuticals, Inc. RPHM | RiverVest Venture Fund III, L.P. | 240,922 10.000% | 240,922 (New Position) | Filing |